ISSN: 2329-6917
Hatem E.Sabaawy
Division of Medical Oncology, The Cancer Institute of New Jersey
New Brunswick, NJ, USA
Hatem E. Sabaawy, M.D., Ph.D., is a Principal Investigator at the Cancer Institute of New Jersey, Director, Production Facility for Cell and Gene therapy, and an Assistant professor of Medicine, Rutgers/Robert Wood Johnson Medical School since 2008. He completed his medical residency in Hematology and graduate training at Cairo University and New York Medical College, Valhalla, NY, USA in 2003. He then completed a fellowship in Transplantation Branch of the National Cancer Institute at NIH, Bethesda, MD in 2007.
Hatem E. Sabaawy, M.D., Ph.D., is a Principal Investigator at the Cancer Institute of New Jersey, Director, Production Facility for Cell and Gene therapy, and an Assistant professor of Medicine, Rutgers/Robert Wood Johnson Medical School since 2008. He completed his medical residency in Hematology and graduate training at Cairo University and New York Medical College, Valhalla, NY, USA in 2003. He then completed a fellowship in Transplantation Branch of the National Cancer Institute at NIH, Bethesda, MD in 2007.